Histo-Scientific Research Laboratories, Inc. (HSRL), has completed its merger with Vet Path Services (VPS) to create the leading provider of research and pre-clinical histology, pathology and archiving services for the biopharmaceutical, medical device and contract research industries.
Kentmere Healthcare Consulting Corporation of Wilmington, Del. said recently that Horizon Healthcare Services, Inc., New Jersey’s oldest and largest health insurer, utilized its services to evaluate, analyze and optimize their outpatient laboratory provider network
Testa Analytical Solutions e.K reports that its Nanobrook ZetaPALS zeta potential analyser is uniquely optimised to make sensitive and precise measurements in both organic and aqueous media
uBiome, the leader in microbial genomics, announces the issue of patent number 9,663,831 entitled “Method and System for Microbiome Analysis” by the US Patent and Trademark Office on May 30, 2017 with a priority date of January 25, 2014
AMSBIO has expanded its range of Wingless/Integrated (Wnt) recombinant proteins, stable reporter cell lines, antibodies and ELISA kits to assist researchers in the fields of developmental biology and oncology
Clustermarket’s platform will allow owners of GE Healthcare Life Sciences instruments to hire out and maximize utilization of high-end biotech technologies.
ZeptoMetrix™ Corporation (ZMC) announced today the release of two significant molecular quality controls to its expanding product inventory
Workpath, a technology company that helps healthcare organizations distribute work opportunities to their labor, announced today the launch of a clinical data exchange platform designed to automate requests from providers needing in-home phlebotomy clinical lab services for their patients
Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, announced recently a collaboration with Edwards Lifesciences focused on improving the detection of heart disease.
On Thursday, December 6, House and Senate lawmakers released bipartisan draft legislation, known as the Verifying Accurate, Leading-edge In Vitro Clinical Test Development (VALID) Act, which outlines a framework for the Food and Drug Administration (FDA) to regulate laboratory developed tests
|
|
|
|
|
|
|
|
|